1. Home
  2. HCWB vs ABVE Comparison

HCWB vs ABVE Comparison

Compare HCWB & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • ABVE
  • Stock Information
  • Founded
  • HCWB 2018
  • ABVE 2019
  • Country
  • HCWB United States
  • ABVE Canada
  • Employees
  • HCWB N/A
  • ABVE N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • HCWB Health Care
  • ABVE Consumer Staples
  • Exchange
  • HCWB Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • HCWB 17.2M
  • ABVE 16.2M
  • IPO Year
  • HCWB 2021
  • ABVE N/A
  • Fundamental
  • Price
  • HCWB $0.39
  • ABVE $0.56
  • Analyst Decision
  • HCWB
  • ABVE
  • Analyst Count
  • HCWB 0
  • ABVE 0
  • Target Price
  • HCWB N/A
  • ABVE N/A
  • AVG Volume (30 Days)
  • HCWB 18.3M
  • ABVE 387.5K
  • Earning Date
  • HCWB 03-31-2025
  • ABVE 02-15-2025
  • Dividend Yield
  • HCWB N/A
  • ABVE N/A
  • EPS Growth
  • HCWB N/A
  • ABVE N/A
  • EPS
  • HCWB N/A
  • ABVE N/A
  • Revenue
  • HCWB $3,495,990.00
  • ABVE $275,376,450.00
  • Revenue This Year
  • HCWB $229.19
  • ABVE N/A
  • Revenue Next Year
  • HCWB N/A
  • ABVE N/A
  • P/E Ratio
  • HCWB N/A
  • ABVE N/A
  • Revenue Growth
  • HCWB 22.27
  • ABVE N/A
  • 52 Week Low
  • HCWB $0.21
  • ABVE $0.34
  • 52 Week High
  • HCWB $2.52
  • ABVE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 48.72
  • ABVE N/A
  • Support Level
  • HCWB $0.38
  • ABVE N/A
  • Resistance Level
  • HCWB $0.42
  • ABVE N/A
  • Average True Range (ATR)
  • HCWB 0.09
  • ABVE 0.00
  • MACD
  • HCWB -0.00
  • ABVE 0.00
  • Stochastic Oscillator
  • HCWB 4.48
  • ABVE 0.00

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: